Notes in 02_Myelodysplastic Syndromes (MDS)

To Subscribe, use this Key

Status	Last Update	Fields
Published	02/10/2024	{{c1::Myelodysplastic syndromes (MDS)}} are {{c2::acquired conditions due to a defect in myeloid stem cells, usually presenting in the elderly, and ar…
Published	02/10/2024	30% of Myelodysplastic Syndromes (MDS) patients will develop {{c1::Acute Myeloid Leukaemia (AML)}}
Published	02/10/2024	Presentation of {{c2::Myelodysplastic Syndromes (MDS)}} {{c1::Elderly (around 70 years of age)}} {{c1::Anaemia (e.g. weakness, fatigue, shortness of b…
Published	02/10/2024	Investigations of Myelodysplastic Syndromes (MDS) {{c1::Full Blood Count (Macrocytic anaemia, Thrombocytopenia, Neutropenia)}} {{c1::Reticulocyte Coun…
Published	02/10/2024	The diagnosis of {{c1::Myelodysplastic Syndromes (MDS)}} is done by {{c2::Bone Marrow Aspirate}} which shows {{c2::Myeloid Blast Cells <2…
Published	02/10/2024	Management of Myelodysplastic Syndromes (MDS) {{c1::Injection of Growth Factors: Erythropoietin or Granulocyte Colony-Stimulating Factor (G-CSF) to in…
Status	Last Update	Fields